No difference was observed in PD-L1+ tumor cells between BCG-R and BCG-NR patients (Fig. 3A), but a higher proportion of biopsies from R expressed PD-L1 in >5% of TILs than in NR (p = 0.051) (Fig. 3B). This evidence concerns the gene CD274 and neoplasm.